Zigang Dong, MD, DrPH, University Minnesota, Twin Cities

Zigang Dong, MD, DrPH

Dr. Dong research focuses on molecular mechanisms of carcinogenesis and prevention of cancer, as well as novel targets and agents for skin cancer prevention and therapy.





  1. Yao K, Lee SY, Peng C, Lim DY, Yamamoto H, Ryu J, Lim TG, Chen H, Jin G, Zhao Z, Han Y, Ma WY, Bode AM, Dong Z. RSK2 is required for TRAF6 phosphorylation-mediated colon inflammation. Oncogene. 2018 Jun;37(26):3501-3513. doi: 10.1038/s41388-018-0167-6. Epub 2018 Mar 22. PubMed PMID: 29563609; PubMed Central PMCID: PMC6023753./li>